Cargando…

Targeting Ca(2+) Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma

SIMPLE SUMMARY: Liver cancer (hepatocellular carcinoma) is a significant health burden worldwide. It is often not detected until at an advanced stage when there are few treatment options available. Changes in calcium concentrations within liver cancer cells are essential for regulating their growth,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Eunus S., Rychkov, Grigori Y., Barritt, Greg J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600741/ https://www.ncbi.nlm.nih.gov/pubmed/32987945 http://dx.doi.org/10.3390/cancers12102755

Ejemplares similares

TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species
por: Ali, Eunus S., et al.
Publicado: (2021)

Curcumin inhibits activation of TRPM2 channels in rat hepatocytes
por: Kheradpezhouh, E., et al.
Publicado: (2015)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling
por: Zhang, Xin, et al.
Publicado: (2023)

TRPM2-mediated Ca(2+) signaling as a potential therapeutic target in cancer treatment: an updated review of its role in survival and proliferation of cancer cells
por: Ali, Eunus S., et al.
Publicado: (2023)

Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling
por: Tsai, M-C, et al.
Publicado: (2015)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2018)

MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL
por: Zou, Wei, et al.
Publicado: (2020)

Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2021)

Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma
por: DiStefano, Johanna K.
Publicado: (2017)

Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
por: Wang, Ru, et al.
Publicado: (2022)

The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma
por: Khan, Suliman, et al.
Publicado: (2022)

Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression
por: Wang, Liyan, et al.
Publicado: (2019)

Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling
por: Liao, Yan, et al.
Publicado: (2017)

PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma
por: Ge, Sijia, et al.
Publicado: (2022)

DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling
por: Xiaoqian, Wang, et al.
Publicado: (2021)

Ca(2+) Transportome and the Interorganelle Communication in Hepatocellular Carcinoma
por: Lai, Hong-Toan, et al.
Publicado: (2022)

Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based Pain
por: Brierley, Stuart M., et al.
Publicado: (2010)

Ubr1-induced selective endophagy/autophagy protects against the endosomal and Ca(2+)-induced proteostasis disease stress
por: Wang, Ben B., et al.
Publicado: (2022)

Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression
por: Tanaka, Y, et al.
Publicado: (2016)

Ca(2+) Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma
por: Bettaieb, Louay, et al.
Publicado: (2021)

Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma
por: Jeng, Kuo-Shyang, et al.
Publicado: (2019)

PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway
por: Tang, Xuming, et al.
Publicado: (2020)

UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway
por: Sun, Jingjie, et al.
Publicado: (2021)

Modulation of TRP Channel Activity by Hydroxylation and Its Therapeutic Potential
por: Nagarajan, Yagnesh, et al.
Publicado: (2017)

Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression
por: Wang, Haichuan, et al.
Publicado: (2021)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

KMO in the promotion of tumor development and progression in hepatocellular carcinoma
por: Xu, Jun, et al.
Publicado: (2023)

TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
por: Zheng, Hao, et al.
Publicado: (2016)

NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma
por: Luo, Xiaoling, et al.
Publicado: (2017)

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020)

Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
por: CAI, TIANYING, et al.
Publicado: (2023)

EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
por: Wang, Bohan, et al.
Publicado: (2023)

MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation
por: Jin, X, et al.
Publicado: (2017)

CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression
por: Lin, L, et al.
Publicado: (2014)

Regulation of Orai1/STIM1 mediated I(CRAC) by intracellular pH
por: Gavriliouk, D., et al.
Publicado: (2017)

Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
por: Massimi, Mara, et al.
Publicado: (2019)

GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2
por: Shao, Na, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vemol3dusnfm6jk541niramf96